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ABSTRAK
Tujuan: mengembangkan sistem skor dan menentukan nilai tambah diagnostik albuminuria dalam 
mengestimasi carotid intima-media thickness (CIMT). Metode: studi potong lintang dilakukan di poliklinik endokrin 
RSCM bulan Maret-Mei 2012 pada pasien DMT2 tanpa komplikasi serebrokardiovaskular, penyakit ginjal kronis 
(PGK) stadium ≥ III, dan tidak merokok. Kami melakukan analisis statistik yang dilanjutkan dengan pembuatan 
sistem skor. Hasil: dari 71 subjek, didapatkan CIMT dan albuminuria masing-masing sebesar 67,6% dan 73,3%. 
Dari 48 subjek dengan CIMT, sebanyak 87,5% mengalami albuminuria. Pemeriksaan albuminuria memiliki 
sensitivitas sebesar 87,5%. Penambahan nilai albuminuria akan meningkatkan AUC sebesar 2,3%. Skor estimasi 
untuk variabel lama terdiagnosis DM, hipertensi, dislipidemia berturut-turut sebesar 1, 2, 1. Skor probabilitas 
CIMT pada skor <2, 2, dan >2 sebesar 15%, 57%, dan 90%. Kesimpulan: pemeriksaan albuminuria meningkatkan 
nilai tambah diagnostik CIMT. Sistem skor dapat digunakan sebagai alat skrining terhadap CIMT pada pasien 
DM tipe 2 tanpa komplikasi serebrokardiovaskular, PGK stadium ≥ III, dan tidak merokok.
Kata kunci: carotid intima-media thickness (CIMT), diabetes melitus tipe 2, albuminuria.
ABSTRACT
Aim: to develop a scoring system and measure the diagnostic added value of albuminuria to estimate CIMT. 
Methods: cross-sectional study was done in Endocrine Outpatient Clinic Cipto Mangunkusumo Hospital between 
March-May 2012 in T2DM patients without history of cerebrocardiovascular event, CKD stage ≥ III, and smoking. 
Bivariate analysis and multivariate (logistic regression) analysis was done, followed by developing the scoring 
system. Results: from 71 subjects, there were 67.6% with increased CIMT and 73.3% with albuminuria. From 48 
subjects with increased CIMT, 87.5% had albuminuria. Albuminuria measurement had high sensitivity (87.5%). 
Adding albuminuria measurement will increase the AUC as 2.3%. Estimation score for duration of DM, hypertension, 
dyslipidemia were as follows 1, 2, 1 respectively. Probability score of increased CIMT for score <2, 2, and >2 was 
as follows 15%, 57%, and 90%. Conclusion: albuminuria measurement increase the diagnostic value of CIMT. 
Scoring system can be used as a screening tool to estimate the increased of CIMT in type 2 DM patients without 
history of cerebrocardiovascular event, CKD stage ≥ III, and smoking.
Keywords: carotid intima-media thickness (CIMT), type 2 diabetes mellitus, albuminuria.
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INTRODUCTION
Cardiovascular event in patient with Type 
2 Diabetes Mellitus (T2DM) are significantly 
related to vascular calcification. Studied by 
Lavranos et al. showed that vascular calcification, 
marked by increasing of Intima Media Thickness 
(IMT) in carotid artery, reach 71% in T2DM 
patients.1
Some studies such as Cardiovascular 
Health Study (CHS)2, Atherosclerosis Risk 
in Communities Study (ARIC)3, the Insulin 
Resistance Atherosclerotic Study (IRAS)4, 
and Carotid Atherosclerosis Progression Study 
(CAPS)5 showed that significant risk factors in 
Carotid Intima Media Thickness (CIMT) are 
diabetes, hypertension, and dyslipidemia, but 
albuminuria has not been measured in those 
studies.
Albuminuria has long been recognized as 
a systemic endothel dysfunction marker and a 
strong determinant for vascular calcification. 
In PREVEND Study (Prevention of Renal and 
Vascular End Stage Disease), albuminuria is 
known to be correlated with cardiovascular 
event, increasing the relative risk in patients with 
albuminuria about 29,1%.6
One of the objective diagnostic test for 
detecting vascular calcification is measuring 
the carotid intima media thickness using carotid 
ultrasound which has sensitivity of 93.4% and 
spesificity of 94%. It has some limitations such 
as operator dependent, limited availability in 
health care facilities, expensive, time-consumed, 
and still not been done as routine investigation 
in general health care facilities.3 Because of the 
limitations and limited application in Indonesia, 
we need other diagnostic method which is not 
invasive, sensitive, spesific, applicable, and not 
expensive. One of the method that can be applied 
generally is scoring system.
Studies on vascular calcification and the 
usage of carotid ultrasound in Indonesia are 
still limited, and there are differences in studies 
about the correlation of albuminuria with carotid 
IMT, so we try to access it with different method. 
This is a diagnostic study by developing scoring 
system which is never been conducted before and 
also we measure the added diagnostic value of 
albuminuria for estimating vascular calcification 
in T2DM patients.
METHODS
This is a cross-sectional study to measure 
albuminuria examination as estimator and 
developing a scoring system, conducted 
in Endocrine Outpat ient  Clinic  Cipto 
Mangunkusumo Hospital in February-May 
2012. Inclusion criteria in this studies are T2DM 
patient. Exclusion criterias are coronary heart 
disease, history of cerebrovascular disease, 
chronic kidney disease stage ≥III, acute infection, 
heart disease, smoking, and anatomical neck 
defect which make difficulty in carotid ultrasound 
examination. There are 71 eligible subjects in 
this study, by using rule of thumb (prevalence 
of CIMT in T2DM from previous study was 
70.5%).
Carotid ultrasound measurement was 
conducted in RCCA (right communis carotid 
artery), LCCA (left communis carotid artery), 
right bulb carotis, and left bulb carotis. CIMT is 
defined as the length between border of intima 
lumen and border of tunica media-adventitia. 
Thickening CIMT is defined as the mean CIMT 
of CCA is higher than normal CIMT, with 
equation: CIMT = 0,4 mm + {(age-21) x 0,01 
mm} or mean CIMT in carotid bulb >0.8 mm.
Statistical analysis was performed by using 
SPSS, with student t-test and Chi-square test. 
Diagnostic power of 5 risk factors were measured 
by area under receiver operating characteristic 
curve (AUC) from estimated probability to 
CIMT from logistic regression multivariate 
analysis and 95% confidence interval.
This studies got Ethical Clearance from 
Ethical Committee of Faculty of Medicine in 
University of Indonesia No.114/PT02.FK/ETIK/ 
2012.
RESULTS
There are 71 eligible subjects in this study 
and the measuring of carotid intima-media 
thickness (CIMT) was presented on Table 1.
In bivariate analysis, the significant risk 
factors related to increased CIMT are duration 
of DM, hypertension, dyslipidemia, and 
albuminuria. Odds ratio with confidence interval 
(CI) 95% was found on Table 2.
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Table 1. Subjects’s characteristics
Characteristic n (%)
Gender - male 31 (43.7)
Age – y.o, mean (SD) 56.3 (9.5)
DM Duration
 - ≥5 years 47 (66.2)
 - <5 years 24 (33.8)
Hypertension
 - Yes 43 (60.6)
 - No 28 (39.4)
HbA1c
 - ≥7% 39 (54.9)
 - <7% 32 (45.1)
Dyslipidemia
 - Yes 55 (77.5)
 - No 16 (22.5)
Albuminuria
 - Yes 50 (70.4)
 - Microalbuminuria 23 (32.4)
 - Macroalbuminuria 27 (38)
 - No 21 (29.6)
Carotid IMT
 - Increased 48 (67.6)
 - plaque (+) 23 (32.4)
 - plaque (-) 25 (35.2)
 - Not Increased 23 (32.4)
 - plaque (+) 10 (14.1)
 - plaque (-) 13 (18.3)
RCCA, median (range) 0.81 (0.41-1.10)
Right bulb carotis, median (range) 1.04 (0.40-1.80)
LCCA, median (range) 0.76 (0.44-1.32)
Left bulb carotis, median (range) 1.04 (0.40-1.80)
Table 2. Analysis of factors related to increase CIMT
Variables
CIMT
OR (CI 95%) p
(-) (+)
Duration of DM
 - ≥5 years 37 10 4.37 0.005
 - <5 years 11 13 (1.5-12.7)
Hypertension
 - Yes 38 5 13.68 <0.001
 - No 10 18 (4.1-16.9)
HbA1c
 - ≥7% 29 10 1.98 0.179
 - <7% 19 13 (0.73-5.43)
Dyslipidemia
 - Yes 41 14 3.76 0.021
 - No 7 9 (1.81-12.0)
Albuminuria
 - Yes 42 8 13.13 <0.001
 - No 6 15 (3.91-11.1)
Fifty-two subjects (73.3%) have albuminuria. 
Sensitivity of albuminuria is 87.5%, but the 
specificity is not high (65.2%). Albuminuria have 
significance in detecting increased carotid IMT 
(p=0.034, OR: 5.385; CI 95%: 1.141-25.43).
Variables included in multivariate analysis 
are variabels in bivariate analysis which give 
significance statistical analysis (p<0.25) which 
are duration of DM, hypertension, HbA1c, 
dyslipidemia, and albuminuria.
The comparison of two analysis models with 
and without albuminuria variable are followed by 
logistic regression to evaluate the added value of 
albuminuria in estimating the increase of CIMT.
Comparison of these two model analysis can 
be seen in ROC curve on Figure 1.
Discrimination quality is measured through 
ROC analysis. AUC (area under the curve) in 
analysis with albuminuria is 0.894 (CI 95%: 
0.811-0.977), and AUC value in analysis without 
albuminuria is 0.871 (CI 95%: 0.774-0.969).
Table 3. Multivariate analysis of related factors
Variables OR (CI 95%) p
Duration of DM 3.4 (0.828-13.963) 0.089
Hypertension 7.728 (1.628-36.680) 0.01
Dyslipidemia 7.381 (1.425-38.217) 0.017
Albuminuria 5.385 (1.141-25.426) 0.034
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Figure 1. ROC curve analysis of albuminuria in estimating 
the increase of CIMT
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Scoring System and Carotid Intima-media 
Thickness Probability
Determinant probability of increased 
CIMT is calculated from multivariate analysis 
(logistic regression) to determine the regression 
coefficient, using three determinant variables. 
According to  the analysis, probability of CIMT 
can be defined through formula with variable 
value as 0 when negative and as 1 when positive:
P =   1        
  1 + e-2,898+1,368 DM +2,741.HT+1,999 Dyslipidemia
Probability range value subject score is 
0-4. Probability total score from the result of 
logistic regression analysis to total score showed 
constanta -2,491 with regression coefficient 
1,389, so the equation is y = -2,491 + (1,389 x 
score total), so the risk class can be classified. 
Estimation score for the duration of DM, 
hypertension, and dyslipidemia are 1, 2, and 1, 
respectively.  The probability of increased carotid 
IMT in score <2, 2, and >2 are: 15%, 57%, and 
90%. (Table 4)
Table 4. Estimation score and probability of increased 
carotid IMT
Patient score Risk class Probability of carotid IMT thickness
<2 Low 15%
2 Medium 57%
>2 High 90%
In analysis to subject score, the sensitivity and 
specificity are 94% and 70%, means if score > 2 , 
it’s a high probability for increased carotid IMT.
DISCUSSION
Prevalence of microalbuminuria in this study 
(30.9%) is similar to some studies like HOPE, 
NHANES III, PREVEND, EPIC, Ausdiab 
Kidney, and CHS, whereas the prevalence of 
microalbuminuria is 30-40% in diabetes mellitus 
population.6
The result of carotid ultrasound in this study 
is 48 subjects (67.6%) have increased carotid 
IMT and 23 subjects (32.4%) do not have 
increased carotid IMT. In 23 subjects (32.4%) 
with no increased of carotid IMT, 10 subjects 
(14.1%) has carotid plaque. This study showed 
the high prevalence of increased CIMT in TDM2 
with no/minor complication.
Study measuring carotid IMT in patient 
with TDM2 in Cipto Mangunkusumo Hospital 
have been conducted previously by Mulya 
in 106 subjects without measuring chronic 
complication. He found the median value of 
RCCA IMT is  0.95 mm (0.520-0.382) and LCCA 
IMT is 0.93 mm (0.040-0.257).7 This value is 
higher compared to our result. This is caused 
by exclusion criterias for study samples which 
excluded subjects with chronic complications.
Determinant Factors
Duration of DM is clinically proven to 
estimate increased of carotid IMT (p=0.089, OR: 
3.4; CI 95% 0.828-13.963) and in this scoring 
system, the score of duration of DM   ≥ 5 years 
is 1. Hypertension is statistically and clinically 
correlated with increased CIMT (p=0.01, OR 
7.728; CI 95% 1.628-36.680) and the score of 
hypertension is 2.
Dyslipidemia also statistically and clinically 
correlated with increased CIMT (p=0.017, OR 
7.381; 95% CI 1.425-38.217) and have score 
1 in subject having  LDL ≥100 mg/dL and/or 
dyslipidemia history or using statin or listed 
in medical report as having dyslipidemia. 
Other study from Viswanathan et al.8 also 
found that LDL cholesterol is statistically and 
clinically significant risk factor for increased 
CIMT.8 Contradictory with the pathophysiology, 
glycemic control represented by glycated 
hemoglobin (HbA1c) do not correlated with 
increased CIMT, so it is not further analyzed.
Albuminuria
Albuminuria has been known as a surrogate 
marker for systemic endothelial dysfunction. It 
can be used as one of determinants of CIMT. 
Albuminuria have significance in detecting 
increased carotid IMT (p=0.034, OR 5.385; CI 
95% 1.141-25.43). IRAS study (The Insulin 
Resistance Atherosclerosis Study) has showed 
that albuminuria increases cerebrocardiovascular 
risk by increased carotid IMT. Albuminuria and 
increased carotid IMT are also related to insulin 
resistance.4
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This result is linear with Chin-Hsun Chu 
et al.9 who found that albuminuria correlated 
significantly with CIMT. Matsagoura et al.10 
also showed that albuminuria has a positive 
correlation with CIMT and as an independent 
predictor for CIMT.
Added Value of Albuminuria to CIMT
Result of AUC in analysis model without 
albuminuria is 0,871 and addition of albuminuria 
examination increase the discrimination to AUC 
0,894. Addition of albuminuria to estimate 
carotid IMT is only 2,3%, therefore it is not 
included in the final model because is not cost-
effective. In the scoring system, we only use three 
determinants (duration of DM, hypertension, and 
dyslipidemia).
Scoring System to Estimate CIMT
Scoring system is developed to help clinicians 
in screening for CIMT. From statistical analysis, 
probability range value is 0-4. Total score 
probability can be calculated with equation: 
y = -2,491 + (1,389 x total score). Total score are 
classified to probability low, medium, and high. 
In sensitivity and specificity analysis to subject 
score, sensitivity is 94% and specificity is 70% 
to score higher than 2, means score higher than 
2 have high probablity to increased CIMT.
Validation of Scoring System
Scoring system validation is conduct in 
minimum of 8 T2DM patients. This scoring 
system is applied to 15 T2DM out of study 
subjects according to inclusion and exclusion 
criteria with the result as Table 5.
Scoring System Cost-effectiveness
Cost-effectiveness comparison of scoring 
system and carotid ultrasound is showed on 
Table 6.
Table 5. Table 2x2 scoring system with carotid IMT
Scoring system
Carotid IMT
Total
Yes No
> 2 10 0 10
≤ 2 3 2 5
Total 13 2 15
From the result of analysis validation test, 
the sensitivity and specificity scoring system 
are 77% and 100%. By this good sensitivity and 
specificity, this scoring system can be applied as 
diagnostic screening tools.
Table 6. Cost-effectiveness comparison of scoring system 
to carotid ultrasound
Scoring system Carotid ultrasound
Sensitivity 77% 93.4%
Specificity 100% 94%
Cost  USD 13 USD 80
Operator Independent Dependent
Time Fast - Flexible Slow
Application Easy Difficult
The comparison show that scoring system 
is more cost-effective compare to carotid 
ultrasound in clinical setting.
Scoring System Clinical Application
Scoring system that has been developed 
is a new diagnostic method that can be use 
as screening tools for detecting CIMT in 
T2DM patients which have not developed 
cerebrocardiovascular disease, CKD stage <3, 
and non-smoker. Patient with total score >2 
could be followed up with carotid ultrasound 
for confirmation, atherosclerosis plaque 
examination, and carotid stenosis level.
Benefit and Limitation of the Study
Benefit of this research is to value the 
diagnostic estimation to carotid IMT. Study 
analysis for albuminuria added value have 
not been done before. In this study, we also 
make validation of scoring system to estimate 
increased carotid IMT in T2DM patients without 
major chronic complication. The main limitation 
in this study is limited sample and specific T2DM 
patients with no or early complication, so the 
result of this study can not be generalized into all 
T2DM population (especially to T2DM patients 
without history of cerebrocardiovascular event, 
CKD stage ≥ III, and smoker).
CONCLUSION
This study shows that the added value 
diagnostic albuminuria examination is only 
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2.3%. Determinant score for duration of DM, 
hypertension, and dyslipidemia are 1, 2, and 1, 
respectively.  The probability of increased CIMT 
in score < 2, 2, and > 2 are 15%, 57%, and 90%. 
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